Time course of rocuronium-induced neuromuscular blockade in pediatric patients: A Phase III, randomized, dose-response study

Journal of Anesthesia and Clinical Research

Volumn 3, Issue 2, 2012, Pages

  Tirotta, Christopher F ^a   Brandom, Barbara ^b   Siddiqui, M Saif ^c   Ehlers, Melissa ^d   Betzel, Jim ^e   Chen, Jin Yi ^e   de Bie, Joris ^e   Blobner, Manfred ^f  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Isoflurane; Neuromuscular blockade; Pediatric; Rocuronium; Sevoflurane

Indexed keywords

EID: 84880003352     PISSN: None     EISSN: 21556148     Source Type: Journal    
DOI: 10.4172/2155-6148.1000189     Document Type: Article

References (27)

1. Brandom BW, Fine GF (2002) Neuromuscular blocking drugs in pediatric anesthesia. Anesthesiol Clin North America 20: 45-58.
2. Fisher DM (1999) Neuromuscular blocking agents in paediatric anaesthesia. Br J Anaesth 83: 58-64.
3. Derendorf H, Hochhaus G (1995) Handbook of Clinical Pharmacokinetic/ Pharmacodynamic Correlation. (1stedn) CRC Press, Florida.
4. Saldien V, Vermeyen KM, Wuyts FL (2003) Target-controlled infusion of rocuronium in infants, children, and adults: a comparison of the pharmacokinetic and pharmacodynamic relationship. Anesth Analg 97: 44-49.
5. Bettelli G (2006) Which muscle relaxants should be used in day surgery and when. Curr Opin Anaesthesiol 19: 600-605.
6. Levy JH, Davis GK, Duggan J, Szlam F (1994) Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N2O/O2-sufentanil anesthesia. Anesth Analg 78: 318-321.
7. Marshall RJ, Muir AW (1995) Rocuronium bromide-A commentary on clinical experience 15 months after introduction. Anesth Pharmacol Rev 3: 188-191.
8. Leykin Y, Pellis T (2005) Determining a Rationale for the Choice of Neuromuscular Blocking Agents in Anaesthesia Practice. Business Briefing: European Pharmacotherapy 2-6.
9. Woelfel SK, Brandom BW, McGowan FX, Gronert BJ, Cook DR (1994) Neuromuscular effects of 600 μgkg-1 of rocuronium in infants during nitrous oxide-halothane anaesthesia. Paediatr Anaesth 4: 173-177.
10. Woelfel SK, Brandom BW, Cook DR, Sarner JB (1992) Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia. Anesthesiology 76: 939-942.
11. Driessen JJ, Robertson EN, Van Egmond J, Booij LH (2000) The time-course of action and recovery of rocuronium 0.3 mg x kg (-1) in infants and children during halothane anaesthesia measured with acceleromyography. Paediatr Anaesth 10: 493-497.
12. Meretoja OA, Taivainen T, Erkola O, Rautoma P, Juvakoski M (1995) Doseresponse and time-course of effect of rocuronium bromide in paediatric patients. Eur J Anaesthesiol Suppl 11: 19-22.
13. Taivainen T, Meretoja OA, Erkola O, Rautoma P, Juvakoski M (1996) Rocuronium in infants, children and adults during balanced anesthesia. Paediatr Anaesth 6: 271-275.
14. Wierda JM, Meretoja OA, Taivainen T, Proost JH (1997) Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children. Br J Anaesth 78: 690-695.
15. Fisher DM, O'Keeffe C, Stanski DR, Cronnelly R, Miller RD, et al. (1982) Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 57: 203-208.
16. Fisher DM, Miller RD (1983) Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia. Anesthesiology 58: 519-523.
17. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC (1998) Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 87: 936-940.
18. Wulf H, Ledowski T, Linstedt U, Proppe D, Sitzlack D (1998) Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 45: 526-532.
19. Xue PS, Liao X, Tong SY, Liu JH, An G, et al. (1998) Dose-response and timecourse of the effect of rocuronium bromide during sevoflurane anaesthesia. Anaesthesia 53: 25-30.
20. Jalkanen L, Meretoja OA (1997) The influence of the duration of isoflurane anaesthesia on neuromuscular effects of mivacurium. Acta Anaesthesiol Scand 41: 248-251.
21. Meretoja OA, Wirtavuori K, Taivainen T, Olkkola KT (1996) Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 76: 235-238.
22. Strum DP, Eger EI (1987) Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 66: 654-656.
23. Eikermann M, Renzing-Köhler K, Peters J (2001). Sevoflurane augments the degree and speeds the onset of rocuronium evoked neuromuscular blockade in children. Anasthesiol Intensivmed Notfallmed Schmerzther 36: 754-758.
24. Malviya S, Lerman J (1990) The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 72: 793-796.
25. Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, et al. (2000) Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 17: 662-664.
26. Loeckinger A, Kleinsasser A, Maier S, Furtner B, Keller C, et al. (2003) Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants during the first 6 months of life. Anesthesiology 98: 639-642.
27. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, et al. (2007) Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 104: 563-568.